rs1554517327
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP2PP3
The NM_007175.8(ERLIN2):c.452C>T(p.Ala151Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
ERLIN2
NM_007175.8 missense
NM_007175.8 missense
Scores
6
10
3
Clinical Significance
Conservation
PhyloP100: 7.58
Genes affected
ERLIN2 (HGNC:1356): (ER lipid raft associated 2) This gene encodes a member of the SPFH domain-containing family of lipid raft-associated proteins. The encoded protein is localized to lipid rafts of the endoplasmic reticulum and plays a critical role in inositol 1,4,5-trisphosphate (IP3) signaling by mediating ER-associated degradation of activated IP3 receptors. Mutations in this gene are a cause of spastic paraplegia-18 (SPG18). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ERLIN2. . Trascript score misZ 3.3024 (greater than threshold 3.09). GenCC has associacion of gene with hereditary spastic paraplegia 18, juvenile primary lateral sclerosis, recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.782
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERLIN2 | NM_007175.8 | c.452C>T | p.Ala151Val | missense_variant | 7/12 | ENST00000519638.3 | NP_009106.1 | |
ERLIN2 | NM_001362878.2 | c.452C>T | p.Ala151Val | missense_variant | 7/12 | NP_001349807.1 | ||
ERLIN2 | XM_047421307.1 | c.452C>T | p.Ala151Val | missense_variant | 8/13 | XP_047277263.1 | ||
ERLIN2 | XM_047421308.1 | c.206C>T | p.Ala69Val | missense_variant | 4/9 | XP_047277264.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERLIN2 | ENST00000519638.3 | c.452C>T | p.Ala151Val | missense_variant | 7/12 | 2 | NM_007175.8 | ENSP00000428112 | P1 | |
ERLIN2 | ENST00000521644.5 | c.452C>T | p.Ala151Val | missense_variant | 7/12 | 5 | ENSP00000429621 | |||
ERLIN2 | ENST00000518526.5 | c.323C>T | p.Ala108Val | missense_variant | 5/8 | 3 | ENSP00000429229 | |||
ERLIN2 | ENST00000521993.3 | n.381C>T | non_coding_transcript_exon_variant | 6/7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia 18a, autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 12, 2023 | - - |
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2018 | Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an ERLIN2-related disease. This sequence change replaces alanine with valine at codon 151 of the ERLIN2 protein (p.Ala151Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Uncertain
Sift
Benign
T;D;D;D
Sift4G
Benign
T;D;D;D
Polyphen
0.41
.;B;B;.
Vest4
0.41
MutPred
0.59
.;Loss of ubiquitination at K149 (P = 0.1651);Loss of ubiquitination at K149 (P = 0.1651);Loss of ubiquitination at K149 (P = 0.1651);
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at